Login
Products
Login
Home
Alerts
Search
Watchlist
Products

SKM Egg Products Export (India) Ltd

SKMEGGPROD
NSE
164.89
2.04%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

SKM Egg Products Export (India) Ltd

SKMEGGPROD
NSE
164.89
2.04%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
868Cr
Close
Close Price
164.89
Industry
Industry
FMCG - Animal/Polutry
PE
Price To Earnings
11.21
PS
Price To Sales
1.24
Revenue
Revenue
699Cr
Rev Gr TTM
Revenue Growth TTM
28.77%
PAT Gr TTM
PAT Growth TTM
102.56%
Peer Comparison
How does SKMEGGPROD stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SKMEGGPROD
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
187210176153162118127135117176202204
Growth YoY
Revenue Growth YoY%
137.858.19.5-15.8-13.1-44.0-27.4-11.7-27.649.158.450.8
Expenses
ExpensesCr
143160134133152101113121105151165161
Operating Profit
Operating ProfitCr
435041201117151412253743
OPM
OPM%
23.323.923.513.36.514.211.610.410.514.118.521.0
Other Income
Other IncomeCr
321193325435
Interest Expense
Interest ExpenseCr
423333233334
Depreciation
DepreciationCr
333333344444
PBT
PBTCr
404737151414121010223340
Tax
TaxCr
101294423336810
PAT
PATCr
303528121012986162530
Growth YoY
PAT Growth YoY%
5,967.4413.8135.3-57.2-66.3-65.8-69.7-35.6-36.534.9187.7299.1
NPM
NPM%
15.916.816.27.66.210.26.85.65.49.312.314.7
EPS
EPS
5.66.75.42.21.92.31.61.41.23.14.75.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
290303232318335313269302662701498699
Growth
Revenue Growth%
10.14.4-23.436.85.3-6.4-14.012.4118.86.0-29.040.4
Expenses
ExpensesCr
252265238315321305237272518550419582
Operating Profit
Operating ProfitCr
3837-63138323114415179117
OPM
OPM%
13.012.4-2.60.94.02.511.910.221.821.515.816.8
Other Income
Other IncomeCr
161323208201381131417
Interest Expense
Interest ExpenseCr
535546449101113
Depreciation
DepreciationCr
131212131114212434403516
PBT
PBTCr
35350568211010311446105
Tax
TaxCr
1011-13134327291227
PAT
PATCr
2525215516776853577
Growth
PAT Growth%
251.2-2.5-93.6-18.1269.5-2.3247.2-54.8927.712.4-59.5123.9
NPM
NPM%
8.88.20.70.41.41.56.12.411.512.27.011.1
EPS
EPS
9.74.70.30.20.90.93.11.414.416.26.614.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
262626262626262626262626
Reserves
ReservesCr
4264656670738894168251277312
Current Liabilities
Current LiabilitiesCr
6568748073938097114129120179
Non Current Liabilities
Non Current LiabilitiesCr
1710781211141630637164
Total Liabilities
Total LiabilitiesCr
151169172181183204210233339469494583
Current Assets
Current AssetsCr
8098106113112135135159237316300392
Non Current Assets
Non Current AssetsCr
7171676870697574102153193191
Total Assets
Total AssetsCr
151169172181183204210233339469494583

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
3730-41714-122626010965
Investing Cash Flow
Investing Cash FlowCr
-2-6-1-7-6-5-17-8-16-54-23
Financing Cash Flow
Financing Cash FlowCr
-37-10-5-5-1-9-10-5-513-25
Net Cash Flow
Net Cash FlowCr
-213-1047-26-1-11396818
Free Cash Flow
Free Cash FlowCr
3424-691-1923-7324832
CFO To PAT
CFO To PAT%
143.6121.0-273.11,280.1291.1-254.0156.725.579.2127.8188.5
CFO To EBITDA
CFO To EBITDA%
97.180.371.8579.4104.8-155.380.36.141.772.483.0

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
39223621422413381123162342568426
Price To Earnings
Price To Earnings
15.79.8130.8177.627.417.47.621.84.56.612.3
Price To Sales
Price To Sales
1.40.80.90.70.40.30.50.50.50.80.9
Price To Book
Price To Book
5.72.62.32.41.40.81.11.41.82.01.4
EV To EBITDA
EV To EBITDA
11.36.7-39.585.511.416.45.37.22.63.85.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
31.131.717.516.421.321.730.529.939.737.734.9
OPM
OPM%
13.012.4-2.60.94.02.511.910.221.821.515.8
NPM
NPM%
8.88.20.70.41.41.56.12.411.512.27.0
ROCE
ROCE%
36.430.33.97.17.48.214.47.139.629.412.8
ROE
ROE%
37.227.61.71.45.04.714.36.239.030.811.4
ROA
ROA%
16.914.70.90.72.62.37.83.222.418.27.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
SKM Egg Products Export (India) Limited is a leading vertically integrated poultry and egg processing company based in India. With a primary production hub in **Erode, Tamil Nadu**, the company has established itself as a high-standard producer for both domestic government contracts and sophisticated international markets. The company is currently undergoing a phase of capital restructuring and geographic expansion to enhance shareholder value and global market share. --- ### **Integrated Production & Biosecurity Infrastructure** The company operates a closed-loop production system designed to mitigate biological risks and ensure consistent product quality. Its infrastructure is characterized by high-level biosecurity protocols and strategic geographic positioning. * **Avian Influenza-Free Status:** The company’s poultry farms are officially recognized by the **Government of India** as an **Avian Influenza-Free Compartment**. This designation is critical for maintaining uninterrupted export operations. * **Pathogen Surveillance:** Continuous monitoring is conducted for **Newcastle disease**, **Salmonella**, and **Avian Influenza**. Physical security measures, such as **chain-link systems** in bird waste areas, are utilized to prevent contact with wild birds and external vectors. * **Geographic Risk Mitigation:** All egg production is concentrated in **Tamil Nadu**. By maintaining **no operations in Kerala**, the company effectively insulates its supply chain from regional avian influenza outbreaks frequently reported in neighboring states. * **State Border Monitoring:** The company maintains enhanced surveillance at state border districts to prevent cross-border transmission of pathogens. --- ### **Revenue Streams & Strategic Market Positioning** SKM Egg Products leverages a dual-market strategy, balancing stable domestic government contracts with high-growth international exports. **Domestic Government Supply** The company is a vital partner to the **Tamil Nadu state government**, recently securing a major contract for **Region-4** under the **PTMGR Nutritious Meal Programme** and the **Integrated Child Development Services (ICDS)**. * **Tendered Quantity:** **28,62,49,572 eggs per annum**. * **Contract Duration:** **One year** (commencing late 2024). **Global Footprint and Expansion** The company operates through a network of international subsidiaries and branches to facilitate global trade: | Entity | Relationship | Location | | :--- | :--- | :--- | | **SKM Europe BV** | Subsidiary | Utrecht, **The Netherlands** | | **SKM Universal Marketing Company India Pvt Ltd** | Associate | India | | **Foreign Branch** | Branch Office | **Russia** | * **Russian Operations:** In **FY25**, the Russian branch reported total assets of **Rs. 3,64,96,215** and total revenues of **Rs. 45,00,05,231**. * **Japan Market Entry:** In **March 2026**, the Board approved the establishment of a **Branch Office in Japan**. This move is intended to capture specific business opportunities in the Japanese market, pending final approvals from the **Reserve Bank of India (RBI)** and Japanese regulatory authorities. --- ### **Capital Restructuring & Shareholder Returns** To improve stock liquidity and encourage retail participation, the company executed a significant capital restructuring in early **2026**. **Stock Split Details (January 2026)** * **Split Ratio:** **1:2** (Sub-division of **1** equity share of **Rs. 10/-** into **2** shares of **Rs. 5/-** each). * **Authorized Share Capital:** **Rs. 30,00,00,000**, divided into **6,00,00,000** equity shares. * **New ISIN:** **INE411D01023**. * **Strategic Intent:** The split was designed to enhance affordability and liquidity without reducing the total value of issued, subscribed, and paid-up capital. **Dividend Track Record** The company maintains a consistent policy of rewarding shareholders through annual dividends: | Metric | FY 2024-25 | FY 2023-24 | | :--- | :--- | :--- | | **Dividend per Share** | **Rs. 1.50** | **Rs. 2.50** | | **Dividend Percentage** | **15%** | **25%** | | **Face Value (Pre-split)** | **Rs. 10** | **Rs. 10** | --- ### **Credit Profile & Financial Governance** The company’s financial stability is supported by reaffirmed credit ratings and a robust governance framework involving state-level stakeholders. **CARE Ratings Affirmation** The company’s creditworthiness reflects a stable outlook and increased borrowing capacity to support its expanding operations: | Facility Type | Amount (Rs. Crore) | Rating | | :--- | :--- | :--- | | **Long-term Bank Facilities** | **54.50** | **CARE A-; Stable** | | **Long-term / Short-term Facilities** | **90.00** (Enhanced) | **CARE A-; Stable / CARE A2+** | | **Short-term Bank Facilities** | **70.00** (Enhanced) | **CARE A2+** | **Governance Highlights** * **TIDCO Representation:** The board includes a **Nominee Director** from the **Tamil Nadu Industrial Development Corporation (TIDCO)**, ensuring alignment with state industrial interests. * **Leadership Continuity:** Independent Directors **Shri. TN Thirukumar** and **Shri. GN Jayaram** have been re-appointed for second five-year terms (through **July 2029**). * **Compliance:** Financials are prepared in accordance with **Indian Accounting Standards (Ind AS)** and **SEBI (LODR) Regulations**. --- ### **Risk Management & Compliance Framework** SKM Egg Products manages a specific set of risks related to the biological nature of its products and its corporate structure. * **Biological Risk:** While the poultry industry is susceptible to disease, the company’s **100% production concentration in Tamil Nadu** and its **Government-recognized disease-free status** serve as primary mitigants. * **Related Party Transactions (RPT):** The company engages in material contracts with related parties that may exceed **10% of annual consolidated turnover**. * **Mitigation:** All such transactions require an **Ordinary Resolution** by shareholders. To ensure transparency, related parties are legally required to **abstain from voting** on these specific resolutions. * **Administrative Support:** Following a merger in **December 2023**, **Link Intime India Private Limited** serves as the Registrar & Share Transfer Agent, ensuring streamlined investor services.